Header Logo

Connection

Poorva Bindal to Rituximab

This is a "connection" page, showing publications Poorva Bindal has written about Rituximab.
Connection Strength

0.804
  1. Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511.
    View in: PubMed
    Score: 0.590
  2. Arun Kumar S, Mishra R, Malempati SC, Bindal P. Primary cardiac large B cell lymphoma. BMJ Case Rep. 2023 Dec 26; 16(12).
    View in: PubMed
    Score: 0.214
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.